These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6098051)

  • 1. Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid.
    Driss F; Vericel E; Lagarde M; Dechavanne M; Darcet P
    Thromb Res; 1984 Dec; 36(5):389-96. PubMed ID: 6098051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane A3 (TXA3) is formed in human platelets after dietary eicosapentaenoic acid (C20:5 omega 3).
    Fischer S; Weber PC
    Biochem Biophys Res Commun; 1983 Nov; 116(3):1091-9. PubMed ID: 6316965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the incubation of long-chain polyunsaturated fatty acids on platelet lipids and thromboxane release.
    Zhang T; Murray M; Klocke K; Miles JM; Holman RT
    Prostaglandins Leukot Essent Fatty Acids; 1997 Apr; 56(4):259-64. PubMed ID: 9150370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of heparin on platelet aggregation and release and thromboxane A2 production.
    Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG
    Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of platelet aggregation and arachidonate metabolism in streptozotocin-diabetic rats.
    Takahashi R; Morita I; Murota S; Ito H
    Prostaglandins Leukot Med; 1986 Dec; 25(2-3):123-9. PubMed ID: 2950527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unsaturated fatty acids inhibit ADP- arachidonate-induced platelet aggregation without affecting thromboxane synthesis.
    Dratewka-Kos E; Tinker DO; Kindl B
    Biochem Cell Biol; 1986 Sep; 64(9):906-13. PubMed ID: 3778664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans.
    von Schacky C; Fischer S; Weber PC
    J Clin Invest; 1985 Oct; 76(4):1626-31. PubMed ID: 2997286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. Effect of albumin on arachidonate metabolism in platelets.
    Rao AK; Koike K; Day HJ; Smith JB; Holmsen H
    Am J Clin Pathol; 1985 Jun; 83(6):687-96. PubMed ID: 3923822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet thromboxane synthesis and release reactions in myeloproliferative disorders.
    Smith IL; Martin TJ
    Haemostasis; 1982; 11(2):119-27. PubMed ID: 6211399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities of aggregation, thromboxane A2 synthesis, and 14C serotonin release in platelets of patients with idiopathic scoliosis.
    Floman Y; Liebergall M; Robin GC; Eldor A
    Spine (Phila Pa 1976); 1983 Apr; 8(3):236-41. PubMed ID: 6623192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelation of platelet aggregation, release reaction and thromboxane A2 production.
    Balduini CL; Bertolino G; Noris P; Sinigaglia F; Bisio A; Torti M
    Biochem Biophys Res Commun; 1988 Oct; 156(2):823-9. PubMed ID: 3190682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of the oral administration of fish oil concentrate on the release and the metabolism of [14C]arachidonic acid and [14C]eicosapentaenoic acid by human platelets.
    Hirai A; Terano T; Hamazaki T; Sajiki J; Kondo S; Ozawa A; Fujita T; Miyamoto T; Tamura Y; Kumagai A
    Thromb Res; 1982 Nov; 28(3):285-98. PubMed ID: 6294902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans.
    von Schacky C; Weber PC
    J Clin Invest; 1985 Dec; 76(6):2446-50. PubMed ID: 3001149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro incorporation and metabolism of icosapentaenoic and docosahexaenoic acids in human platelets--effect on aggregation.
    Croset M; Lagarde M
    Thromb Haemost; 1986 Aug; 56(1):57-62. PubMed ID: 3022414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome.
    Jackson CA; Greaves M; Patterson AD; Brown CB; Preston FE
    Br J Haematol; 1982 Sep; 52(1):69-77. PubMed ID: 6810912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of supplementation with unsaturated fatty acids on plasma and membrane lipid composition and platelet function in patients with cirrhosis and defective aggregation.
    Marra F; Riccardi D; Melani L; Spadoni S; Galli C; Fabrizio P; Tosti-Guerra C; Carloni V; Gentilini P; Laffi G
    J Hepatol; 1998 Apr; 28(4):654-61. PubMed ID: 9566835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the ratio of exogenous eicosapentaenoic acid to arachidonic acid on platelet aggregation and serotonin release.
    Hashimoto Y; Naito C; Kawamura M; Oka H
    Thromb Res; 1984 Jun; 34(5):439-46. PubMed ID: 6330926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine.
    Stuart MJ; Dusse J; Clark DA; Walenga RW
    Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.